Period Ending | Dec 28, 2012 | Sep 28, 2012 | Jun 29, 2012 | Mar 30, 2012 |
---|
Total Revenue
|
54,512,000
|
35,966,000
|
35,023,000
|
39,186,000
| Cost of Revenue | 33,452,000 | 21,565,000 | 20,029,000 | 20,622,000 | |
Gross Profit
|
21,060,000
|
14,401,000
|
14,994,000
|
18,564,000
| |
|
Operating Expenses |
|
Research Development | 1,010,000 | 906,000 | 876,000 | 841,000 |
|
Selling General and Administrative | 2,840,000 | 2,551,000 | 2,545,000 | 2,339,000 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
17,210,000
|
10,944,000
|
11,573,000
|
15,384,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 462,000 | (51,000) | 288,000 | 148,000 |
|
Earnings Before Interest And Taxes | 17,672,000 | 10,893,000 | 11,861,000 | 15,532,000 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 17,672,000 | 10,893,000 | 11,861,000 | 15,532,000 |
|
Income Tax Expense | 4,594,000 | 2,670,000 | 3,037,000 | 3,910,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 13,078,000 | 8,223,000 | 8,824,000 | 11,622,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
13,078,000
|
8,223,000
|
8,824,000
|
11,622,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
13,078,000
|
8,223,000
|
8,824,000
|
11,622,000
|
|